Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Eisai’s Sleep Inducer Dayvigo Accepted in Hong Kong
July 9, 2020
- Lenvima-Keytruda Combo’s 1st Line HCC Bid Nixed in US after Rival Nod
July 9, 2020
- Patient Numbers Remain Down at Over 60% of Hospitals Even after Emergency Lifted: Survey
July 9, 2020
- Aducanumab Filing Completed in US; Talks with Japan/EU Regulators Ongoing
July 9, 2020
- Medicago, GSK Team Up to Develop Adjuvanted COVID-19 Vaccine, PI to Commence in Mid-July
July 9, 2020
- GSK in Quest for Best COVID-19 Vaccine, Not the First: Japan Chief Lirette
July 8, 2020
- Sales Rep Promotions in May Tank 67% YOY: Intage
July 8, 2020
- Japan Ethical Drug Sales Slide 12.0% in May: Crecon
July 8, 2020
- EU Regulators Accept Enhertu for Accelerated Review for HER2-Positive Breast Cancer
July 8, 2020
- Sunovion’s Bipolar Depression Med Fails to Show Statistically Significant Improvement in PII
July 8, 2020
- Keytruda Snatches Back Top Crown in June Drug Sales Ranking: Encise
July 7, 2020
- Amgen Takes Over Japan MA for Otezla
July 7, 2020
- Eisai Launches Dayvigo, Fycompa Fine Granules in Japan
July 7, 2020
- Ono to Fight Prof. Honjo’s Lawsuit over Opdivo Royalties
July 7, 2020
- Chugai Aspires to Become World Top Innovator Post-COVID-19 Era: President
July 7, 2020
- Maviret Shrivels, but AbbVie Japan in “Growth Mode” with Oncology, Immunology Drivers: Chief
July 3, 2020
- GSK Japan Sets Up Women’s Leadership Initiative to Bring Diversity in Managerial Ranks
July 3, 2020
- Daiichi Sankyo Adds Patients with Triple Negative Breast Cancer into PI DS-1062 Study
July 3, 2020
- Nobelpharma Launches European Subsidiary in Germany
July 3, 2020
- Fujifilm Inks Global Avigan Deal with Dr. Reddy’s, Global Response Aid
July 2, 2020
ページ
The number of newly listed generic drugs in Japan has fallen sharply over the past decade, reflecting structural changes in…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…